Month: May 2022
-
Medical News
FDA nod for Roche drug expands its use to babies with spinal muscular atrophy
A Roche drug that treats spinal muscular atrophy is now approved for treating babies younger than 2, providing those…
Read More » -
Medical News
Death from alcohol-related liver disease could be prevented with early diagnosis and intervention, says new study
Credit: Pixabay/CC0 Public Domain Patients dying of alcohol-related liver disease had frequent interactions with secondary care services prior to their…
Read More » -
Medical News
A collaboration seeks to build healthy routines to help end the nation’s mental health crisis
The youth mental health crisis was dire before the pandemic, but it has only been exacerbated over the last two…
Read More » -
Medical News
Promoting prostate cancer tests in men without symptoms should be approached with caution
Prostate cancer cells. Credit: NIH Image Gallery Inviting people who don’t have symptoms to be screened for prostate cancer is…
Read More » -
Medical News
A ‘dark horse’ emerges in DNA sequencing race, boasting a $100 genome
Bay Area biotech Ultima Genomics on Tuesday claimed that its technology can sequence a whole human genome for $100, making…
Read More » -
Medical News
Researchers make a novel discovery in age-related macular degeneration
Schematic showing the function(s) of cell adhesion molecules, cytokines, and chemokines. Credit: Aging-US.com A new research paper has been published…
Read More » -
Medical News
Frustrations Remain 2 Years After UCNS Certification Switch
Headache medicine expert Joel Saper, MD once saw the formation of the United Council for Neurologic Subspecialties as a sign…
Read More » -
Medical News
A multi-pronged effort needed to ensure all patients with obesity get better care
When a person with diabetes, high blood pressure, or osteoarthritis goes to their primary care clinic, they expect treatment that’s…
Read More » -
Medical News
Kymriah Gets Accelerated Approval for Relapsed/Refractory Follicular Lymphoma
The Food and Drug Administration (FDA) has granted accelerated approval to Kymriah® (tisagenlecleucel), a CD19-directed genetically modified autologous T-cell immunotherapy,…
Read More » -
Medical News
Dupilumab Gets Priority Review for Prurigo Nodularis
The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for dupilumab for…
Read More »